- Education
-
Research
Current research
Talent
-
Collaboration
Businesses
Government agencies and institutions
Alumni
-
About AU
Organisation
Job at AU
Coronary artery disease in heart transplant patients
2021.04.08 |
| Date | Thu 22 Apr |
| Time | 15:15 — 17:15 |
| Location | Online via Zoom |
On Thursday 22 April at 15:15, Kamilla Pernille Bjerre Valen defends her PhD dissertation entitled "Cardiac Allograft Vasculopathy in heart transplant recipients: Mechanisms and progression".
Coronary artery disease (CAV) after heart transplantation (HTx) is a frequent and feared complication that attacks both the coronary arteries and small blood vessels in the heart. As CAV is often asymptomatic, invasive CAV monitoring with coronary angiography (CAG) is necessary every one or two years after HTx, exposing patients to risks and discomfort. The cause of CAV is very complex and not fully elucidated. The treatment options are limited and include, among other things, platelet inhibitor treatment with aspirin as in common coronary artery disease. In this Ph.D. thesis, the aims were to investigate possible mechanisms involved in the development of CAV as well as the effect of treatment with aspirin in HTx patients. In addition, the purpose was to investigate whether non-invasive echocardiographic methods could be used for screening for CAV.
The summary is written by the PhD student.
The defence is public and takes place online via Zoom. Please read the attached press release for more information.
PhD student Kamilla Pernille Bjerre Valen
Mail: kambje@rm.dk
Phone: (+45) 53535832